SCHEMBL3772307

SCHEMBL3772307

COc1cccc(I)c1S(N)(=O)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 15/20 0.45
CA1 P00915 13/20 0.44
ACHE P22303 2/20 0.44
CA12 O43570 9/20 0.42
CA9 Q16790 8/20 0.42
LMNA P02545 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PTGES2 Q9H7Z7 1/20 0.39
CA14 Q9ULX7 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6807395 0.86 CA2 (0.51) CA2CA1ACHECA12CA9
SCHEMBL32665057 0.81 CA2 (0.41) CA2CA1ACHECA12CA9
SCHEMBL32665374 0.81 CA2 (0.40) CA2CA1ACHECA12CA9
SCHEMBL1804716 0.80 CA2 (0.48) CA2CA1ACHECA12CA9
SCHEMBL3600104 0.79 CA2 (0.46) CA2CA1ACHECA12CA9
SCHEMBL1131641 0.79 ALDH1A1 (0.52) CA2CA1ACHECA12CA9
SCHEMBL31536843 0.79 CA2 (0.46) CA2CA1ACHECA12CA9
SCHEMBL3773786 0.78 CA12 (0.45) CA2CA1CA12CA9LMNA
SCHEMBL6731762 0.78 CA2 (0.47) CA2CA1ACHECA12CA9
SCHEMBL5399765 0.78 PTGES2 (0.54) CA2CA1ACHECA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7855166-B2 Sulfonylamino(thio)carbonyl compounds BAYER CROPSCIENCE GMBH (DE) 2010-12-21 US disclosed
US-7855166-B2 Sulfonylamino(thio)carbonyl compounds BAYER CROPSCIENCE GMBH (DE) 2010-12-21 US disclosed
US-20100317524-A1 Sulfonylureas BAYER CROPSCIENCE AG (DE) 2010-12-16 US disclosed
US-20100317524-A1 Sulfonylureas BAYER CROPSCIENCE AG (DE) 2010-12-16 US disclosed
EP-1877386-A1 HERBICIDALLY ACTIVE PHENYLSULPHONYL-UREA Bayer CropScience AG (DE) 2008-01-16 EP disclosed
EP-1877380-A1 SULFONYLAMINO(THIO)CARBONYL COMPOUNDS IN THE FORM OF HERBICIDES OR PLANT GROWTH REGULATORS BAYER CROPSCIENCE AG (DE) 2008-01-16 EP disclosed
US-20060264329-A1 Sulfonylureas BAYER CROPSCIENCE GMBH (DE) 2006-11-23 US disclosed
US-20060258536-A1 Sulfonylamino(thio)carbonyl compounds BAYER CROPSCIENCE GMBH (DE) 2006-11-16 US disclosed
EP-1717228-A1 Sulfonylamino(thio)carbonylderivatives as herbicides or plant growth regulators Bayer CropScience GmbH (DE) 2006-11-02 EP disclosed
EP-1717232-A1 Phenylsulfonylureas with herbicidal activity Bayer CropScience GmbH (DE) 2006-11-02 EP disclosed
WO-2006114221-A1 SULFONYLAMINO(THIO)CARBONYL COMPOUNDS IN THE FORM OF HERBICIDES OR PLANT GROWTH REGULATORS BAYER CROPSCIENCE AG (DE) 2006-11-02 WO disclosed
WO-2006114220-A1 HERBICIDALLY ACTIVE PHENYLSULPHONYL-UREA BAYER CROPSCIENCE AG (DE) 2006-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317524-A1 Sulfonylureas IAPP, SLC5A2, SLC5A1 CA2 418/4885CA1 1524/4885ACHE 713/4885
US-20060258536-A1 Sulfonylamino(thio)carbonyl compounds TST, CBR3, MYB CA2 3775/4885CA1 4582/4885ACHE 4239/4885
US-20060264329-A1 Sulfonylureas INSR, FFAR3, GPR119 CA2 1646/4885CA1 2058/4885ACHE 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.